Summary 1. Once-daily edoxaban dosing regimens are associated with less bleeding than twice-daily regimens 2. Edoxaban, at 30 or 60 mg OD, appears to have a safety profile similar to that of warfarin (target INR of 2 to 3)
Weitz JI. Presented at the 50th American Society for Hematology meeting. 12-7-2008 San Francisco, CA